EMEA-001146-PIP01-11-M04

Key facts

Invented name
Moventig
Active substance
Naloxegol
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0056/2019
PIP number
EMEA-001146-PIP01-11-M04
Pharmaceutical form(s)
  • Tablet
  • Age-appropriate oral liquid formulation
Condition(s) / indication(s)
Treatment of opioid-induced constipation
Route(s) of administration
Oral use
Contact for public enquiries
Kyowa Kirin Pharmaceutical Development Limited

Tel.  +44 1896664000
E-mail: RegOps@kyowa-kirin-pharma.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating